News | July 17, 2023
Evonik and Heraeus cooperate to expand the range of services for highly potent API
Evonik specializes in mid- to large-scale, later clinical phase HPAPIs
Evonik specializes in mid- to large-scale, later clinical phase HPAPIs
Advances clinical research capabilities with leading regulatory grade registries platform
Adding 20,000 liters of installed biologics drug substance manufacturing capacity
Investment will help fuel international partnerships, grow IGX Platform functionality, and diversify proposition with new generative AI solutions
Exothera will manufacture Meissa’s MV-012-968 vaccine candidate under CGMP regulations to supply Phase 2 clinical trials
Oncodesign Services and ImaginAb sign a Preclinical License and Supply Agreement
Supply readiness follows months of manufacturing to ensure timely and ample supply
The booster vaccine can be administered safely to individuals who have received two doses of either Covaxin or Covishield
Convergent action on AMR identified as an important area of intervention
Panacea Biotec has announced the launch of its new range of high-quality pediatric food & nutritional products
Subscribe To Our Newsletter & Stay Updated
